Plastic in My French Fries?

Image: Getty Images Every research scientist knows that discovery often depends as much on happenstance--serendipity--as it does on methodical searching. If a group of researchers from Stockholm didn't know it earlier, they certainly learned the lesson over the last five years. The presence of acrylamide bound to hemoglobin in laboratory workers who perform polyacrylamide gel electrophoresis--a commonly used method to separate and analyze proteins-- wasn't necessarily surprising, but when Emma

Written byBarry Palevitz
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Every research scientist knows that discovery often depends as much on happenstance--serendipity--as it does on methodical searching. If a group of researchers from Stockholm didn't know it earlier, they certainly learned the lesson over the last five years. The presence of acrylamide bound to hemoglobin in laboratory workers who perform polyacrylamide gel electrophoresis--a commonly used method to separate and analyze proteins-- wasn't necessarily surprising, but when Emma Bergmark of Stockholm University also found it in people who didn't work with the reagent, it was indeed puzzling.1 So a group led by Margareta Tornqvist, also of Stockholm University, decided to find out how the chemical-- a known neurotoxin and possible human carcinogen--found its way into the bloodstream of John and Jane Andersson.

Preliminary data indicated that acryl-amide levels are much lower in wild animals, so the researchers wondered if people ingest it in food. And, because it is also found in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies